Trichodesma indicum (L.) R.Br.

Avakpushpi
Section/Chapter Herb database/Avakpushpi
Botanical name(s) Trichodesma indicum (L.) R.Br.
Family Boraginaceae
Availability Available
Contributors Team Dravyaguna
Year of publication 2026
Publisher Charak Samhita Research, Training and Skill Development Centre
DOI Awaited

Trichodesma indicum (L.) R.Br., known in Ayurveda as Avakpushpi (also Adhahpushpi or Adhapushpi), is a hispid, erect or diffuse annual herb of the family Boraginaceae. It grows as a common weed across most of India and on stony, dry wastelands of Pakistan, and extends to Bhutan and Myanmar.[1] The name refers to its flowers, which hang downward ("adhah" = downward, "pushpa" = flower); the Tamil name Adhapushpi carries the same meaning.[1] Among the species of the genus Trichodesma, T. indicum is regarded as the most important in terms of reported pharmacological value.[2]

English name

Indian borage[1]

Therapeutic Use

The following uses are reported in Indian folk and ethnobotanical practice (Sanskrit disease terms are given as the nearest Ayurvedic equivalents): Atisara and Pravahika (diarrhoea and dysentery), Jwara (fever), Kasa (cough and cold), Shotha (swelling, anasarca), Sandhishula and Vatarakta-type complaints (joint pain, arthritis), Vrana (wounds, cuts and bleeding), Twak roga (skin diseases), Visha (snake bite), Mutra roga (urinary diseases), Aruchi (anorexia), Krimi (intestinal worms) and Karnashula (ear pain). The whole plant is also described as emollient and diuretic.[2][1]

Other Varieties / Other Botanical names

  • Borago indica L. (basionym)


Synonyms in Charak Samhita

Avakpushpi, Adhapushpi

Ayurvedic pharmacological properties

Properties
Sr.no. Pharmacological criteria Properties
1 Taste (rasa) Pungent (katu), Bitter (tikta)
2 Potency (veerya) Hot (ushna)
3 Post digestion effect (vipaka) Pungent (katu)
4 Qualities (guna) Light (laghu)
5 Actions (karma) Pacify vata and kapha

Reference in Charak Samhita and its actions

Herbs and their activities
Sr.no. Reference in Charak Samhita Activity
1 Cha.Sa.Chikitsa Sthana 7/114 Ingredient in Kanakakshiri Taila (Kushtha Chikitsa chapter)
2 Cha.Sa.Chikitsa Sthana 14/234 As an ingredient of Sunishannaka Changeri Ghrita (Arsha Chikitsa chapter)

Dose

  • Paste of root- 5 to 10 g
  • Juice of plant- 10 to 20 ml

Important Formulations

As per Charak Samhita:

  • Kanakakshiri Taila
  • Sunishannaka Changeri Ghrita

Current availability

Available

  • In India – Common weed in plains, wastelands and dry stony ground throughout most parts of the country.[1]
  • Out of India –
  • South Asia – Pakistan (Karachi, Sindh, Balochistan, Chitral, Swat, Hazara, Poonch, Kashmir and adjoining areas), Bhutan[1]
  • Southeast Asia – Myanmar[1]

Current researches

Phytochemical Composition

Phytochemical work on T. indicum (aerial parts, root, seed oil) has identified compounds from several classes.[1][2]

  • Triterpenoids and Sterols: α-amyrin, lupeol, β-sitosterol, stigmast-5-en-3β-ol-23-one, stigmast-5-en-3β-ol-21(24)-olide and lanast-5-en-3β-D-glucopyranosyl-21(24)-olide.
  • Fatty acids, Esters and Hydrocarbons: Oleic, linoleic, palmitic, stearic and linolenic acids (seed oil); n-decanyl laurate, n-tetradecanyl laurate, n-nonacosanyl palmitate, hexacosane, n-pentacos-9-one and n-dotriacont-9-one-13-ene.
  • Phenolics: Gallic acid and catechin; preliminary screening also indicates phenolic compounds, flavonoids, tannins and terpenoids.
  • Pyrrolizidine Alkaloids (PAs): Supinine, europine, heliotrine, echimidine and a monocrotaline-type alkaloid have been reported. These are of toxicological significance (see Safety).[3][2]
  • Other Constituents: Free and protein amino acids (e.g. aspartic acid, glutamic acid, proline, cysteine, tryptophan) and mucilage.[2]

Pharmacological Activities & Therapeutic Efficacy

Almost all evidence for T. indicum comes from in vitro assays and animal models. Mechanisms below are those proposed by the study authors; they are not established in humans.

Anti-inflammatory Activity

Root extract has been evaluated against acute and chronic inflammation, which supports its traditional use in swelling and joint complaints.

  • Mechanism: Inhibition of mediator-driven oedema (histamine, serotonin, dextran and carrageenan pathways) and of granulation tissue formation. A contribution from lipoxygenase inhibition is suggested by in vitro enzyme inhibition (about 64.5%) in a separate screening study.[4]
  • Scientific Evidence: In rats, a root extract at 50, 100 and 200 mg/kg dose-dependently reduced carrageenan, dextran, histamine and serotonin-induced paw oedema. At 200 mg/kg the carrageenan oedema was inhibited by 48.12%, compared with 54.32% for indomethacin. In the cotton-pellet granuloma model the extract reduced granuloma weight modestly (approximately 15–21%), less than indomethacin (about 29%) and dexamethasone (about 34%).[5]

Analgesic and Antipyretic Activity

  • Mechanism: Peripheral action through reduced synthesis or release of inflammatory mediators, with a possible central component suggested by the tail-immersion and early-phase formalin results. The antipyretic effect is proposed to involve prostaglandin biosynthesis.[1]
  • Scientific Evidence: In mice, an ethanol root extract (100, 200 and 400 mg/kg) significantly inhibited acetic acid-induced writhing, and 400 mg/kg raised the pain threshold in the tail-immersion test and inhibited both phases of the formalin test, with a stronger effect on the late phase. In yeast-induced pyrexia in rats the extract lowered rectal temperature with an effect similar to aspirin.[1]

Antidiarrhoeal and Antispasmodic Activity

Root decoction is widely taken in India for diarrhoea, dysentery and stomach upset, and this use has been tested experimentally.

  • Mechanism: Reduced intestinal propulsion and reduced intestinal fluid accumulation, along with relaxation of intestinal smooth muscle.[6][4]
  • Scientific Evidence: An ethanol root extract inhibited castor oil-induced diarrhoea in rats, decreased propulsion of a charcoal meal and reduced castor oil-induced intestinal fluid accumulation.[6] In isolated rabbit jejunum, a plant extract reduced spontaneous and agonist-induced contractions, with about 78% inhibition at 5 mg/mL.[4]

Antitussive Activity

  • Mechanism: Not established; the effect was observed on the cough reflex in an animal model.
  • Scientific Evidence: In mice, a methanolic extract of the whole plant significantly reduced the frequency of sulphur dioxide-induced cough at all tested doses. The effect lasted up to 90 minutes and was comparable to codeine phosphate, supporting the folk use in cough.[7]

Diuretic Activity

  • Mechanism: Increased urine output with sodium excretion greater in the methanolic extract and potassium excretion greater in the aqueous extract; the methanolic extract behaved like a potassium-sparing diuretic.[8]
  • Scientific Evidence: In rats (Lipschitz model), methanolic extract of the aerial parts at 300 mg/kg produced a significant diuretic effect (Lipschitz value 1.25) relative to furosemide.[8] This is consistent with traditional use in Shotha and Mutra roga.

Anti-diabetic Activity

  • Mechanism: α-Amylase inhibition and enhanced glucose uptake in muscle cells.
  • Scientific Evidence: A methanolic leaf extract showed moderate α-amylase inhibition (IC50 91.3 µg/mL) and significantly lowered blood glucose in streptozotocin-nicotinamide induced type 2 diabetic rats, alongside glibenclamide.[9] A hydroalcoholic whole-plant extract showed moderate glucose uptake in L6 myotubes.[10]

Antimicrobial Activity

  • Mechanism: Not defined; among the compounds isolated from the root, a lanostane-type glycoside showed the strongest activity.
  • Scientific Evidence: An ethanol root extract inhibited Staphylococcus aureus, Bacillus subtilis and Candida albicans (MIC 19.2 µg/mL), and the isolated lanostane glycoside lanast-5-en-3β-D-glucopyranosyl-21(24)-olide inhibited S. aureus with an MIC of 2.4 µg/mL.[1] Extracts were also active in disc-diffusion tests against B. subtilis, S. aureus, Pseudomonas aeruginosa, Proteus vulgaris, C. albicans, Aspergillus flavus and A. niger.[11]

Antiproliferative Activity (Preliminary)

  • Scientific Evidence: A shoot extract reduced the mitotic index in an antimitotic assay,[12] and ethanol extract showed stronger cytotoxicity than chloroform extract against MCF-7 (breast), HeLa (cervical) and HEp2 (laryngeal) cell lines.[13] Other work found poor cytotoxicity of a hydroalcoholic extract against L6 cells,[10] so findings are inconsistent. These are screening results only and do not support use of the plant as an anticancer treatment.

Safety, Toxicity, and Dosage

  • Pyrrolizidine Alkaloid Content: T. indicum contains 1,2-unsaturated pyrrolizidine alkaloids such as heliotrine, echimidine, europine and supinine.[3][2] Alkaloids of this type are associated with liver injury, including hepatic sinusoidal obstruction syndrome, after ingestion of PA-containing plants; their N-oxides can also be converted back to toxic PAs in the body.[14] Internal use of raw or unprocessed plant material, repeated or long-term use, and high doses should therefore be avoided.
  • Who Should Avoid Internal Use: Pregnant and lactating women, children, and persons with liver disease or taking hepatotoxic medicines, unless explicitly supervised by a qualified physician.
  • Classical Preparations: In the Charak Samhita the herb occurs as one ingredient among many in a medicated oil and a medicated ghee. Whether such processing alters PA content has not been studied in the literature reviewed, so no safety assurance can be drawn from classical use.
  • Acute Toxicity: No formal LD50 or sub-chronic toxicity data for T. indicum in a modern guideline study were identified in the sources reviewed.
  • Standard Therapeutic Dosage: Not established (see Dose). Preclinical doses should not be translated to humans.

Limitations of Current Evidence

  • No randomized controlled trial or other controlled human study of T. indicum was identified in the literature reviewed.
  • Most studies use crude extracts with limited chemical standardization, different plant parts and different solvents, which limits comparison between studies.
  • Several reports are in vitro only, and findings such as cytotoxicity are preliminary.
  • Future work should include HPLC-based quantification of pyrrolizidine alkaloids, sub-chronic toxicity and hepatic safety studies, and clinical evaluation of Charak Samhita formulations that contain Avakpushpi.

Summary of Therapeutic Profile

Therapeutic Applications of Trichodesma indicum
Indication Active Biomolecules / Extract Primary Pharmacological Action Level of Evidence
Inflammation, Swelling, Joint Pain Root extract; triterpenoids and sterols Inhibition of mediator-induced oedema and granuloma Animal (rat)
Pain and Fever Ethanol root extract Analgesic (peripheral and possibly central), antipyretic Animal (mouse, rat)
Diarrhoea and Dysentery Ethanol root extract Reduced intestinal propulsion and fluid accumulation, antispasmodic Animal (rat), ex vivo (rabbit jejunum)
Cough Methanolic whole-plant extract Suppression of SO2-induced cough reflex Animal (mouse)
Oedema, Urinary Complaints Methanolic aerial-part extract Diuresis (K+-sparing pattern) Animal (rat)
Type 2 Diabetes Methanolic leaf extract α-Amylase inhibition, blood glucose reduction In vitro, animal (rat)
Bacterial and Fungal Infections Ethanol root extract; lanostane glycoside Antibacterial, antifungal In vitro

References

  1. ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 Mangai, S. A. (2018). "Pharmacological efficacy of Trichodesma indicum (Linn) R. Br. in folk medicine – an updated review". Asian Journal of Pharmaceutical and Clinical Research. 11 (3): 24–27. doi:10.22159/ajpcr.2018.v11i3.24412. 
  2. ↑ 2.0 2.1 2.2 2.3 2.4 2.5 Abdelgawad, A. A. M.; El-Bassossy, T. A. I.; Ahmed, F. A. (2021). "A review on phytochemical, pharmacological and ethnopharmacological aspects of genus Trichodesma". Indian Journal of Natural Products and Resources. 12 (3): 333–347. 
  3. ↑ 3.0 3.1 Ahmad, L.; He, Y.; Semotiuk, A.; Liu, Q. (2018). "Qualitative determination of toxic pyrrolizidine alkaloids in Trichodesma indicum: a prevalent ethnomedicine of Northern Pakistan". Journal of Complementary Medicine Research. 9 (2): 11–23. 
  4. ↑ 4.0 4.1 4.2 Khan, T.; Ahmad, M.; Ahmad, W.; Saqib, Q. N.; Choudhary, M. I. (2009). "Preliminary evaluation of the antispasmodic and lipoxygenase inhibitory effects of some selected medicinal plants". Pharmaceutical Biology. 47: 1137–1141. 
  5. ↑ Perianayagam, J. B.; Sharma, S. K.; Pillai, K. K. (2006). "Anti-inflammatory activity of Trichodesma indicum root extract in experimental animals". Journal of Ethnopharmacology. 104 (3): 410–414. 
  6. ↑ 6.0 6.1 Perianayagam, J. B.; Sharma, S. K.; Pillai, K. K. (2005). "Evaluation of anti-diarrhoeal potential of Trichodesma indicum root extract in rats". Methods and Findings in Experimental and Clinical Pharmacology. 27 (8): 533–537. 
  7. ↑ Srikanth, K.; Murugesan, T.; Kumar, C. A.; Suba, V.; Das, A. K. (2002). "Effect of Trichodesma indicum extract on cough reflex induced by sulphur dioxide in mice". Phytomedicine. 9 (1): 75–77. 
  8. ↑ 8.0 8.1 Manani, L. M.; Kakrani, P.; Saluja, A. K. (2014). "Evaluation of diuretic activity of Trichodesma indicum (L.) R. Br. in rats". International Journal of Pharma and Bio Sciences. 5 (2): 129–133. 
  9. ↑ Narendra, K.; Prasad, M. S.; Joshi, D. S.; Reddi, K. V.; Swathi, J. (2015). "Anti-diabetic activity of Trichodesma indicum (L) leaf extracts". Journal of Biological Sciences Opinion. 3 (6): 259–265. 
  10. ↑ 10.0 10.1 Sudharshan, R. D.; Srinivasa, R. A.; Ananth, P. H. (2012). "In vitro antioxidant and glucose uptake effect of Trichodesma indicum in L-6 cell lines". International Journal of Pharma and Bio Sciences. 3 (4): 810–819. 
  11. ↑ Saboo, S. S.; Tapadiya, G. G.; Khadabadi, S. S. (2013). "Antimicrobial potential of tropical plant Trichodesma indicum and Trichodesma sedgwickianum". Research Journal of Microbiology. 8 (1): 63–69. 
  12. ↑ Saboo, S. S.; Tapadiya, G. G.; Lamale, J. J.; Khadabadi, S. S. (2014). "Phytochemical screening and antioxidant, antimitotic and antiproliferative activities of Trichodesma indicum shoot". Ancient Science of Life. 34 (2): 113–118. 
  13. ↑ Mangai, S. A.; Subban, R. (2014). "In vitro cytotoxicity of Trichodesma indicum Linn R.Br. extracts against three human cancer cell lines". Asian Journal of Pharmaceutical and Clinical Research. 7: 103–105. 
  14. ↑ Yang, M.; Ruan, J.; Gao, H.; Li, N.; Ma, J.; Xue, J.; Ye, Y.; Fu, P. P.; Wang, J.; Lin, G. (2017). "First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans". Archives of Toxicology. doi:10.1007/s00204-017-2013-y. 

Herbs

Return to "Avakpushpi" page.